We are live on ! Find out more
ACHN

Achillion Pharmaceuticals
ACHN

Delisted

ACHN was delisted on the 27th of January, 2020.

Back to rankings

122 hedge funds and large institutions have $707M invested in Achillion Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 122 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

103% more call options, than puts

Call options by funds: $42.6M | Put options by funds: $21M

Holders
122
Holders Change
+122
Holders Change %
–
% of All Funds
3.98%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.1%
New
122
Increased
–
Reduced
–
Closed
–
Calls
$42.6M
Puts
$21M
Net Calls
+$21.7M
Net Calls Change
+$21.7M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CS
51
Credit Suisse
Switzerland
$2.04M +$1.9M +249,286 New
Charles Schwab
52
Charles Schwab
California
$1.58M +$1.44M +189,096 New
Deutsche Bank
53
Deutsche Bank
Germany
$1.53M +$1.44M +188,001 New
AllianceBernstein
54
AllianceBernstein
Tennessee
$1.45M +$1.36M +177,797 New
CCI
55
Columbus Circle Investors
$1.42M +$1.33M +174,081 New
California State Teachers Retirement System (CalSTRS)
56
California State Teachers Retirement System (CalSTRS)
California
$1.38M +$1.28M +168,258 New
Ameriprise
57
Ameriprise
Minnesota
$1.29M +$1.21M +157,869 New
TA
58
Teachers Advisors
New York
$1.06M +$985K +129,062 New
MAA
59
Managed Account Advisors
New Jersey
$1.04M +$973K +127,489 New
PCM
60
Prelude Capital Management
New York
$1.02M +$949K +124,332 New
DCM
61
DAFNA Capital Management
California
$996K +$930K +121,800 New
Barclays
62
Barclays
United Kingdom
$979K +$915K +119,818 New
Axa
63
Axa
France
$961K +$897K +117,541 New
N
64
Nuveen
North Carolina
$926K +$864K +113,162 New
WMSA
65
Weiss Multi-Strategy Advisers
New York
$900K +$840K +110,000 New
PAMU
66
Pictet Asset Management (UK)
United Kingdom
$863K +$805K +105,500 New
KIA
67
Kopp Investment Advisors
Minnesota
$837K +$781K +102,312 New
ACH
68
ArrowMark Colorado Holdings
Colorado
$784K +$732K +95,891 New
American Century Companies
69
American Century Companies
Missouri
$751K +$696K +91,130 New
California Public Employees Retirement System
70
California Public Employees Retirement System
California
$750K +$700K +91,700 New
RhumbLine Advisers
71
RhumbLine Advisers
Massachusetts
$732K +$683K +89,519 New
HT
72
HAP Trading
New York
$669K +$624K +81,751 New
HI
73
HBK Investments
Texas
$652K +$608K +79,700 New
MLICM
74
Metropolitan Life Insurance Company (MetLife)
New York
$639K +$597K +78,153 New
Nomura Holdings
75
Nomura Holdings
Japan
$612K +$571K +74,736 New
1 2
3
4 5

ACHN Hedge Fund Activity: Q2 2013 in Review

122 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Achillion Pharmaceuticals (ACHN) for Q2 2013, worth a combined $707M.

Buyers outnumbered sellers: 122 funds opened new ACHN positions and 0 closed out — a net gain of 122 holders — while 0 added to existing stakes and 0 trimmed.

  • 122 institutional investors held Achillion Pharmaceuticals (ACHN) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $707M of Achillion Pharmaceuticals stock for Q2 2013.
  • 122 funds opened new Achillion Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +122 holders.

Based on aggregated 13F filings for Q2 2013.